The 7-point Σhape plus
AIMS TO:
Ck1+
Lift the cheek1
For lifting and firming skin2*†‡
Ck4+
Define the mandible angle1
For lifting and firming skin2*†‡
Jw1+
Elongate the chin1
C1
Lift the jawline1 Jw4+ Improve chin height1
For lifting and firming skin2*†‡ C2
Jw5+
Please refer to the QR code for additional information and considerations. Adverse events should be reported.
Graphical representation of the MD Codes is for illustrative purposes only. Position of MD Codes on the face adapted from de Maio M, 2021 and UK reporting forms and information can be found at https://
de Maio M, 2022.1,3 Codes suitable for treatment with JUVÉDERM® or HArmonyCa Lidocaine are indicated with an orange plus symbol. The aims [Link] or via the MHRA YellowCard app, available at
of effects in orange are specific to HArmonyCa Lidocaine treatment. The aims that have been provided are specific for the 7-point Σhape plus Google Play or Apple App stores. Adverse events should also be
strategy. Products selected for use from the JUVÉDERM® range must be on-label and aligned with the product Directions for Use. These reported to AbbVie on ProductSurveillance_EAME@[Link]
recommendations are provided by Dr Maurício de Maio (CRM/SP 69331 RQE 14478) and are based on his extensive experience and articles Irish HCPs are asked to report any suspected adverse reactions via
published in peer-reviewed journals. C: chin; Ck: cheek; Jw: jawline. HPRA Pharmacovigilance; website: [Link].
For HCP training purposes only – not for patient-facing use | Developed and funded by Allergan Aesthetics, an AbbVie company UK-MULT-240015 | Date of preparation: June 2024
The 7-point Σhape plus
1,4 Active number
MD Codes Product Target layer Injection device Delivery Notes1,4
per side (mL)1,4§
Ck1 anchor VM5‖ Supraperiosteal1,4¶ Needle1,4** Bolus1,4 0.1 + 0.1+ 0.1††
VM5‖ Sub-SMAS level1,4 Cannula1,4,6 Linear1,4 0.5‡‡
Ck1 curve
HACa7 Subcutaneous8 Cannula8 Fanning8 0.25§§
VM5‖ Subcutaneous1,4 Cannula1,4,6 Fanning1,4 0.5‡‡
Ck4 Be wary of the parotid gland
HACa7 Subcutaneous8 Cannula8 Fanning8 0.5§§¶¶
VX9‖ Subcutaneous1,4 Cannula1,4 Fanning1,4 0.5‖‖
C1 Be wary of the sublabial artery
VM5‖ Subcutaneous1,4 Cannula1,4,6 Fanning1,4 0.5‖‖
VX9‖ Subcutaneous1,4 Cannula1,4 Bolus1,4 0.3‖‖
C2
VM5‖ Subcutaneous1,4 Cannula1,4,6 Bolus1,4 0.3‖‖
Supraperiosteal1,4¶ Needle1,4** Bolus1,4 0.5
VX9‖
Jw1 Subcutaneous1,4 Cannula1,4 Fanning1,4 0.5 Be wary of the parotid gland
HACa7 Subcutaneous8 Cannula8 Fanning8 0.5§§¶¶
VX9‖ Subcutaneous1,4 Cannula1,4 Linear1,4 0.5
Jw4 Be wary of the submental artery
HACa7 Subcutaneous8 Cannula8 Fanning8 0.25§§
VX9‖ Subcutaneous1,4 Cannula1,4 Linear1,4 0.5
Jw5 Be wary of the submental artery
HACa7 Subcutaneous8 Cannula8 Fanning8 0.25§§
For the aim of making the chin more C2/VX9‖/supraperiosteal¶/needle**/bolus/0.3 mL (midline)
Be wary of the submental artery
triangular, consider C2 midline:1,4 C2/VM5‖/supraperiosteal¶/needle**/bolus/0.3 mL (midline)
C2 may be injected with VM5‖ or VX9‖ at the supraperiosteal level¶ or
Additional consideration for C2:1,4 subcutaneous level with needles on the right and left sides, with bolus Be wary of the submental artery
technique, and the active number is 0.3 mL per side
Additional consideration for Jw4:1,4 Jw4/VX9‖/supraperiosteal¶/needle**/bolus/0.3 mL Be wary of the submental artery
Please refer to the QR code for additional information and considerations.
¶Do not inject into the bone, but rather at the level of the bone. 4 **Aspiration is highly recommended when injecting with a needle at the level of the bone. 4
C: chin; Ck: cheek; HACa: HArmonyCa Lidocaine; Jw: jawline; SMAS: superficial muscular aponeurotic system; VM: JUVÉDERM® VOLUMA®.
VX: JUVÉDERM® VOLUX .
